Precision Medicine Group announced the acquisition of Project Farma. It is a patient-focused company in the field of bioengineering services that supports innovators in the field of life sciences in creating and improving modern therapies. Project Farm enriches Precision with cutting-edge expertise in the production of life-changing drugs and its unique focus on the rapidly growing field of cell and gene therapy. The acquisition of Project Farm means making better use of the potential of end-to-end cell and gene therapy and gaining unique expertise to support development and commercialization.

Project Farm, led by CEOs Anshol Mangal, John Khoury and Tony Khoury, has distinguished itself as a global leader in the planning and implementation of comprehensive biological production strategies and facilities for clients - from start-up biotechnology companies to global biopharmaceutical companies and academic medical centers. The company has run more than a dozen manufacturing plants with capital investments of more than $ 1 billion (including plants for some of the most widely used FDA-approved cell and gene therapy drugs).

Commenting on the acquisition , Mark Clein , CEO of Precision Medicine Group, said: "Precision has supported more than 70% of FDA-approved cell and gene therapies since 2013. It is now in an even better position to support hundreds of new therapy players. Thanks to our acquisition of Project The farm is Precision, the only life sciences company that has real options for end-to-end cell and gene therapy. ”

Project Farm will now be part of Precision for Medicine, PMG's research and development industry. Commenting on the acquisition, President of Precision for Medicine, Chad Clark , explains: "In today's highly competitive and proven market for advanced therapies, the difference between success and failure can be to ensure safe, scalable and high quality manufacturing capacity. "The comprehensive cell and gene therapy services available through Precision ADVANCE leverage their know-how, and this collaboration deepens it."

"We are excited to join the Precision team, which means we will be able to leverage interconnected services and accelerate the development, production and commercialization of advanced therapies," said Anshul Mangal . "We recognize that Precision ADVANCE represents an incredible opportunity to take the next generation of drugs to the next level and to fulfill the combined mission of Project Farm and Precision to positively impact as many patients and families as possible," added Tony Khoury .

To learn more about Project Farma's innovative organic production and validation services, visit projectfarma.com .

To learn more about Project Farm and the end-to-end cellular and gene therapy capabilities of Precision ADVANCE, visit: precisionmedicinegrp.com/advance .

About Precision Medicine Group
Precision Medicine Group was founded in 2012. It is a specialized service company that supports next-generation practices in drug development and commercialization. Precision provides an integrated infrastructure that supports pharmaceutical and biological companies in developing new products in today's precision medicine. The company is headquartered in Bethesde, Maryland with offices in North America and Europe. Learn more at precisionmedicinegrp.com .

About Precision for Medicine
Precision for Medicine is the first biomarker organization to provide clinical research services and supports life sciences companies in using the biomarkers necessary to target patients more accurately and effectively. Precision applies new biomarker procedures to clinical research that integrate clinical trials with in-depth scientific and laboratory knowledge and advanced data science. This convergence of studies, laboratories and data sciences is leading to faster clinical development and validation. Precision for Medicine is part of the Precision Medicine Group, which includes more than 2,100 people in 35 locations in the US, Canada and Europe. Learn more at PrecisionForMedicine.com .

About Project Farma
Project Farma is a consulting company dealing with organic production from its planning to implementation. Project Farm services include the provision of technical operational strategies, such as the evaluation and mobilization of a business plan, decisions on the production or purchase of a product, the implementation of GMP infrastructure and the implementation of projects. They also include the implementation of the strategy through the management of capital projects, the selection and management of CDMOs, technology transfers and the construction of facilities, and the provision of engineering services in the areas of automation, validation, quality, reliability and maintenance. Project Farm's clients include start-ups, established life sciences corporations, innovative treatment organizations, universities, hospitals, government agencies, financial institutions, non-profit organizations and CRO / CMO. For more information, visitprojectfarma.com..

About the Cell and Gene Therapy Team, Precision ADVANCE
Precision ADVANCE connects services and teams in a unique position to respond to complex clinical, regulatory, manufacturing and commercial needs and to successfully market cell or gene therapies. For more information, visit precisionmedicinegrp.com/advance .

Media contact:
Louis Landon , Precision Medicine Group Media Relations
310-984-7707
louis.landon@precisionformedicine.com

 

Source: prnewswire.com

Report Abuse